phase 1_2_completion
saveJiangsu Hengrui Pharmaceuticals Co Ltd — adebrelimab (Phase I/II Trial Completion)
community read0 votes
Therapy area: Oncology. Indication: Non-Small Cell Lung Cancer
Data sources
globaldata
Found something off?
drug timeline · 2
same company · ±60 days · 2
related news · 1
🐶 often sniffed alongside
top 6- tagOncology6 co-mentions · 3 sources
- tagNSCLC3 co-mentions · 2 sources
- tagPulmonology2 co-mentions · 2 sources
- companyJiangsu Hengrui Pharmaceuticals Co Ltd1 co-mentions · 1 sources
- companyHospital Of Dalian Medical University 11 co-mentions · 1 sources
- companyNanfang Hospital of Southern Medical University1 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that